| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cocrystal Pharma, Inc. (COCP) has 8 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. COCP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 49.2K | $49.2K | - | |
| CEO | 49.2K | $49.2K | - | |
| 10% | 24.6K | $24.6K | - | |
| ? | 24.6K | $24.6K | - | |
| ? | 16.4K | $16.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2015 | Meckler Jeffrey A45 | Chief Executive Officer | Buy | 100,000 | $0.58 | $57,870.00 | +38.0% | |
| Apr 21, 2015 | Schinazi Raymond F | Director, 10% Owner | Buy | 3,464,855 | $0.92 | $3,187,666.60 | +1.3% | |
| Mar 25, 2015 | Wilcox Gary | Chief Executive Officer | Buy | 54,348 | $0.92 | $50,000.16 | +0.3% | |
| Mar 25, 2015 | Meckler Jeffrey A45 | Director | Buy | 163,043 | $0.92 | $149,999.56 | +163.0% | |
| Mar 25, 2015 | Hsiao Jane Ph D65 | Director | Buy | 2,200,000 | $0.92 | $2,024,000.00 | New | |
| Mar 25, 2015 | Rubin Steven D68 | Director | Buy | 54,348 | $0.92 | $50,000.16 | +8.5% | |
| Mar 25, 2015 | Block David S | Director | Buy | 108,696 | $0.92 | $100,000.32 | New | |
| Mar 25, 2015 | Frost Phillip Md Et Al48 | Director, 10% Owner | Buy | 3,464,855 | $0.92 | $3,187,666.60 | +3.5% |